Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Proteolysis inducing-factor"'
Autor:
Darpan I. Patel, Derek Wallace, Kira Abuchowski, Paul Rivas, Amber Gallegos, Nicolas Musi, Addanki Pratap. Kumar
Publikováno v:
Physiological Reports, Vol 7, Iss 16, Pp n/a-n/a (2019)
Abstract Muscle loss is a debilitating side effect to prostate cancer (PCa) experienced by nearly 60% of men. The purpose of this study was to test the hypothesis that Nexrutine®, a bark extract from the Phellodendrum amurense, can protect against p
Externí odkaz:
https://doaj.org/article/00bf1b87b0fa4220a62981c7a6f3ecd8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moreira, Dayson Friaça
A expressão do PIF/DCD em tumores tem sido relacionada ao crescimento e resistência à morte celular e à indução de caquexia em camundongos. O objetivo deste estudo foi investigar o papel do PIF/DCD nestes processos. Foram construídos três PIF
Autor:
Paul Rivas, Amber Gallegos, Addanki P. Kumar, Derek Wallace, Nicolas Musi, Darpan I. Patel, Kira Abuchowski
Publikováno v:
Physiological Reports, Vol 7, Iss 16, Pp n/a-n/a (2019)
Physiological Reports
Physiological Reports
Muscle loss is a debilitating side effect to prostate cancer (PCa) experienced by nearly 60% of men. The purpose of this study was to test the hypothesis that Nexrutine®, a bark extract from the Phellodendrum amurense, can protect against prostate c
Autor:
Mohamad Assi, Amélie Rébillard
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Hindawi, 2016, 2016, pp.1-19. ⟨10.1155/2016/9579868⟩
Oxidative Medicine and Cellular Longevity, Vol 2016 (2016)
Oxidative Medicine and Cellular Longevity, 2016, 2016, pp.1-19. ⟨10.1155/2016/9579868⟩
Oxidative Medicine and Cellular Longevity, Hindawi, 2016, 2016, pp.1-19. ⟨10.1155/2016/9579868⟩
Oxidative Medicine and Cellular Longevity, Vol 2016 (2016)
Oxidative Medicine and Cellular Longevity, 2016, 2016, pp.1-19. ⟨10.1155/2016/9579868⟩
International audience; Chronic inflammation and excessive loss of skeletal muscle usually occur during cancer cachexia, leading to functional impairment and delaying the cure of cancer. The release of cytokines by tumor promotes the formation of rea
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael J. Tisdale
Publikováno v:
Current Opinion in Supportive & Palliative Care. 2:256-261
This review compares the catabolic actions of tumour necrosis factor-alpha (TNF-alpha) and proteolysis-inducing factor (PIF) and their involvement in human cancer cachexia.TNF-alpha has a direct catabolic effect on skeletal muscle and adipose tissue,
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 5, Iss 3, Pp 337-344 (2008)
Evidence-Based Complementary and Alternative Medicine, Vol 5, Iss 3, Pp 337-344 (2008)
We determined the therapeutic efficacy of atractylenolide I (ATR), extracted from largehead atractylodes rhizome, in managing gastric cancer cachexia (GCC), and interpreted its probable pharmacological mechanism via investigating tumor necrosis facto
Autor:
Michael J. Tisdale, Stacey M. Wyke
Publikováno v:
British Journal of Cancer
Loss of skeletal muscle in cancer cachexia has a negative effect on both morbidity and mortality. The role of nuclear factor-kappaB (NF-kappaB) in regulating muscle protein degradation and expression of the ubiquitin-proteasome proteolytic pathway in
Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle
Autor:
Michael J. Tisdale, Kamran A. Mirza
Publikováno v:
British Journal of Cancer
Background: Cachexia in both mice and humans is associated with tumour production of a sulphated glycoprotein called proteolysis-inducing factor (PIF). In mice PIF binds with high affinity to a surface receptor in skeletal muscle, but little is known